Vivione Biosciences Inc. (TSXV:VBI) announced a non-brokered private placement of up to 864,000 units at CAD 0.25 per unit for gross proceeds of up to CAD 216,000 on January 29, 2014. Each unit will consist of one class A common share and one half of one non-transferable class A common share purchase warrant. Each full warrant entitles the holder to purchase one class A common share at an exercise price of CAD 0.35 for a period of 24 months. The closing is expected to occur prior to February 14, 2014 and is subject to the completion of formal documentation and receipt of regulatory approval, including the conditional approval of the TSX Venture Exchange Inc. All securities will have a hold period of four months and one day.

On February 20, 2014, Vivione Biosciences Inc. closed the transaction. The company issued the shares to new investor, Arkansas Venture Capital Investment Trust. The hold period of the securities issued will expire on June 20, 2014. The company has issued securities pursuant to Regulation D.